Suheung Capsul - Asset Resilience Ratio
Suheung Capsul (008490) has an Asset Resilience Ratio of 0.99% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 008490 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Suheung Capsul's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Suheung Capsul.
Liquid Assets Composition Over Time
This chart breaks down Suheung Capsul's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Suheung Capsul to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩10.52 Billion | 0.99% |
| Total Liquid Assets | ₩10.52 Billion | 0.99% |
Asset Resilience Insights
- Limited Liquidity: Suheung Capsul maintains only 0.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Suheung Capsul Industry Peers by Asset Resilience Ratio
Compare Suheung Capsul's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Suheung Capsul (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Suheung Capsul.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.99% | ₩10.52 Billion ≈ $7.13 Million |
₩1.06 Trillion ≈ $719.12 Million |
-0.11pp |
| 2024-12-31 | 1.10% | ₩11.22 Billion ≈ $7.60 Million |
₩1.02 Trillion ≈ $689.68 Million |
+0.12pp |
| 2023-12-31 | 0.98% | ₩9.71 Billion ≈ $6.58 Million |
₩993.74 Billion ≈ $673.44 Million |
-1.32pp |
| 2022-12-31 | 2.30% | ₩21.30 Billion ≈ $14.43 Million |
₩926.42 Billion ≈ $627.82 Million |
+1.33pp |
| 2021-12-31 | 0.97% | ₩7.85 Billion ≈ $5.32 Million |
₩809.95 Billion ≈ $548.89 Million |
-1.47pp |
| 2020-12-31 | 2.44% | ₩18.68 Billion ≈ $12.66 Million |
₩765.99 Billion ≈ $519.10 Million |
+1.29pp |
| 2019-12-31 | 1.15% | ₩8.14 Billion ≈ $5.51 Million |
₩708.86 Billion ≈ $480.39 Million |
+0.87pp |
| 2018-12-31 | 0.28% | ₩1.78 Billion ≈ $1.21 Million |
₩639.10 Billion ≈ $433.11 Million |
+0.03pp |
| 2017-12-31 | 0.25% | ₩1.49 Billion ≈ $1.01 Million |
₩595.29 Billion ≈ $403.42 Million |
-0.68pp |
| 2016-12-31 | 0.93% | ₩5.43 Billion ≈ $3.68 Million |
₩585.89 Billion ≈ $397.05 Million |
+0.20pp |
| 2015-12-31 | 0.73% | ₩4.05 Billion ≈ $2.74 Million |
₩556.75 Billion ≈ $377.30 Million |
-0.01pp |
| 2014-12-31 | 0.73% | ₩3.60 Billion ≈ $2.44 Million |
₩491.21 Billion ≈ $332.88 Million |
-0.06pp |
| 2013-12-31 | 0.79% | ₩3.69 Billion ≈ $2.50 Million |
₩466.55 Billion ≈ $316.17 Million |
+0.45pp |
| 2012-12-31 | 0.34% | ₩1.60 Billion ≈ $1.08 Million |
₩466.47 Billion ≈ $316.12 Million |
+0.31pp |
| 2011-12-31 | 0.03% | ₩138.40 Million ≈ $93.79K |
₩434.23 Billion ≈ $294.27 Million |
-0.08pp |
| 2010-12-31 | 0.11% | ₩410.00 Million ≈ $277.85K |
₩359.76 Billion ≈ $243.80 Million |
-1.94pp |
| 2009-12-31 | 2.05% | ₩5.23 Billion ≈ $3.54 Million |
₩255.24 Billion ≈ $172.97 Million |
-5.26pp |
| 2008-12-31 | 7.31% | ₩18.75 Billion ≈ $12.71 Million |
₩256.71 Billion ≈ $173.97 Million |
-9.87pp |
| 2007-12-31 | 17.18% | ₩33.02 Billion ≈ $22.38 Million |
₩192.26 Billion ≈ $130.29 Million |
+7.19pp |
| 2006-12-31 | 9.99% | ₩16.42 Billion ≈ $11.13 Million |
₩164.35 Billion ≈ $111.38 Million |
-3.29pp |
| 2005-12-31 | 13.28% | ₩21.00 Billion ≈ $14.23 Million |
₩158.14 Billion ≈ $107.17 Million |
+13.18pp |
| 2003-12-31 | 0.10% | ₩105.34 Million ≈ $71.39K |
₩110.72 Billion ≈ $75.03 Million |
-4.18pp |
| 2002-12-31 | 4.27% | ₩4.88 Billion ≈ $3.31 Million |
₩114.22 Billion ≈ $77.41 Million |
+0.99pp |
| 2001-12-31 | 3.29% | ₩4.01 Billion ≈ $2.72 Million |
₩122.19 Billion ≈ $82.81 Million |
-9.78pp |
| 2000-12-31 | 13.06% | ₩17.12 Billion ≈ $11.60 Million |
₩131.06 Billion ≈ $88.81 Million |
-- |
About Suheung Capsul
Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver… Read more